Ombretta Lenzi

1,2,4-Triazolo[4,3-<i>a</i>]quinoxalin-1-one Moiety as an Attractive Scaffold To Develop New Potent and Selective Human A₃ Adenosine Receptor Antagonists:  Synthesis, Pharmacological, and Ligand−Receptor Modeling Studies

Vittoria Colotta, Daniela Catarzi, Flavia Varano et al. · Journal of Medicinal Chemistry · 2004 · 67 citations · Full text

Adenosine Receptors, Attractive Scaffold, Receptor Antagonists +16

1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: Synthesis, biological evaluation, and molecular modeling study

Flavia Varano, Daniela Catarzi, Vittoria Colotta et al. · Bioorganic & Medicinal Chemistry · 2005 · 65 citations

Molecular Pharmacology, Molecular Modeling Study, Biochemistry +10

New 2-Arylpyrazolo[3,4-<i>c</i>]quinoline Derivatives as Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies

Vittoria Colotta, Daniela Catarzi, Flavia Varano et al. · Journal of Medicinal Chemistry · 2007 · 58 citations · Full text

4-Amido-2-aryl-1,2,4-triazolo[4,3-<i>a</i>]quinoxalin-1-ones as New Potent and Selective Human A₃Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand−Receptor Modeling Studies

Ombretta Lenzi, Vittoria Colotta, Daniela Catarzi et al. · Journal of Medicinal Chemistry · 2006 · 56 citations · Full text

1,2,4-Triazolo[1,5-<i>a</i>]quinoxaline as a Versatile Tool for the Design of Selective Human A₃Adenosine Receptor Antagonists:  Synthesis, Biological Evaluation, and Molecular Modeling Studies of 2-(Hetero)aryl- and 2-Carboxy-Substitued Derivatives

Daniela Catarzi, Vittoria Colotta, Flavia Varano et al. · Journal of Medicinal Chemistry · 2005 · 51 citations · Full text